Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

I wonder how the head of CVS is feeling this morning?

Posted by: Aaron Pressman on November 8, 2006

After watching a ton of election coverage last night all across the TV dial, I went to sleep around 1 a.m. I think I must have seen about 117 interviews with Rahm Emanuel, the Illinois congressman who ran the House Democratic campaign committee. And when I woke up at at the crack of dawn, or should I say when the kids woke me up at the crack of dawn, he was still on (despite what Republicans say, Emanuel is obviously no vampire).

And yet one message of Emanuel’s penetrated my sleepy brain with crystal clarity: Democrats plan to rewrite the Medicare prescription drug benefit to allow the government to negotiate prices directly with drug companies. While that idea was certainly in the air before Democrats took over the House (and maybe the senate), I hadn’t heard it put at the top of the priority list so clearly until last night. And with the magnitude Republican losses, it’s hard to imagine President Bush putting up much of a fight on that one.

Investors were no doubt listening, too. For stocks, what’s been a boon, even a boondoggle, for some drug companies and pharmacy benefit managers looks likely to become a big pain.

Check out the stock charts for pharmacy benefit managers since President Bush signed the Medicare Part D program into law at the end of 2003 until this September when Walmart (WMT) announced its own drug discount program. Among the big three, Caremark (CMX) more than doubled, Express Scripts (ESRX) almost tripled and Medco Health Solutions (MHS) lagged with a 75% gain. The S&P 500 gained about 18% over the same period.

It was a great climb for savvy investors but get ready for the other side of the mountain, coming at 9:30 when trading opens. I wonder how Tom Ryan, the CEO of drug store chain CVS (CVS) is feeling this morning?

Post a comment



Bloomberg Businessweek’s Ben Steverman focuses on the latest moves in financial markets and emerging trends in stocks, bonds, and funds, always with an eye toward giving readers a better understanding of the sometimes confusing and often chaotic world of money. Standard & Poor’s senior index analyst Howard Silverblatt will also provide his take on companies’ finances and the markets. Voted one of the “Top 100 Finance Blogs” in 2007.

BW Mall - Sponsored Links

Buy a link now!